Jody Berry

Title: Jody Berry: Innovator in Immunoassays and Engineered Proteins

Introduction

Jody Berry is a notable inventor based in Easton, PA (US). He has made significant contributions to the field of biotherapeutics, particularly in the development of immunoassays and engineered proteins. With a total of 4 patents, his work focuses on advancing treatments related to immune checkpoint inhibitors.

Latest Patents

Berry's latest patents include innovative technologies such as immunoassays and engineered proteins for monitoring antibody treatments to the immune checkpoint inhibitors PD1 and PD-L1. These fusion proteins comprise an extracellular domain of PD1 and/or PD-L1 proteins. The extracellular domains are expressed in specific configurations and purified as proteins, which are then utilized in immunoassays to monitor the circulating levels of biotherapeutic antibodies. Additionally, he has developed a method for determining the circulating levels of a biotherapeutic antibody in biological samples from patients who have undergone immunotherapy. Another significant patent involves a composition comprising recombinant GPlbα receptor protein, which relates to recombinant polypeptides that specifically bind human von Willebrand Factor.

Career Highlights

Throughout his career, Jody Berry has worked with prominent companies in the biotechnology sector. Notable among these are Grifols Diagnostic Solutions Inc. and F. Hoffmann-La Roche AG. His experience in these organizations has contributed to his expertise in the development of innovative therapeutic solutions.

Collaborations

Berry has collaborated with several professionals in his field, including Elizabeth Booth and John Andrew Hall. These partnerships have likely enhanced his research and development efforts, leading to impactful innovations.

Conclusion

Jody Berry's contributions to the field of immunoassays and engineered proteins demonstrate his commitment to advancing biotherapeutic treatments. His innovative patents and collaborations reflect his significant role in the biotechnology industry.